Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
1,830
Views
0
CrossRef citations to date
0
Altmetric
Research Article

MiR-140 targets lncRNA FAM230B to suppress cell proliferation in acute myeloid leukemia running title: MiR-140 targets FAM230B in AML

Yan Wanga Department of hematopathology, Hainan Cancer Hospital, Haikou City, People’s Republic of China
,
Fangfang Wangb Department of traditional Chinese medicine, Hainan Cancer Hospital, Haikou City, People’s Republic of China
,
Yang Lua Department of hematopathology, Hainan Cancer Hospital, Haikou City, People’s Republic of China
,
Yan Lia Department of hematopathology, Hainan Cancer Hospital, Haikou City, People’s Republic of China
,
Haonan Ranc Department of radiotherapy, Hainan Cancer Hospital, Haikou City, People’s Republic of China
,
Feihu Yand Department of Integrated Chinese and Western Medicine, Hainan Cancer Hospital, Haikou City, People’s Republic of China
&
Yuyang Tiana Department of hematopathology, Hainan Cancer Hospital, Haikou City, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 700-705 | Published online: 06 Jun 2022

References

  • Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152. doi:10.1056/NEJMra1406184.
  • Estey E. Acute myeloid leukemia: 2016 update on risk-stratification and management. Am J Hematol. 2016;91(8):824–846. doi:10.1002/ajh.24439.
  • Prada-Arismendy J, Arroyave JC, Röthlisberger S. Molecular biomarkers in acute myeloid leukemia. Blood Rev. 2017;31(1):63–76. doi:10.1016/j.blre.2016.08.005.
  • Lagunas-Rangel FA, Chávez-Valencia V, Gómez-Guijosa M, et al. Acute myeloid leukemia-genetic alterations and their clinical prognosis. Int J Hematol Oncol Stem Cell Res. 2017;11(4):328–339.
  • Grimwade D, Ivey A, Huntly BJ. Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance. Blood. 2016;127(1):29–41. doi:10.1182/blood-2015-07-604496.
  • Dombret H, Gardin C. An update of current treatments for adult acute myeloid leukemia. Blood. 2016;127(1):53–61. doi:10.1182/blood-2015-08-604520.
  • Ossenkoppele G, Löwenberg B. How I treat the older patient with acute myeloid leukemia. Blood. 2015;125(5):767–774. doi:10.1182/blood-2014-08-551499.
  • Cortes JE, Heidel FH, Fiedler W, et al. Survival outcomes and clinical benefit in patients with acute myeloid leukemia treated with glasdegib and low-dose cytarabine according to response to therapy. J Hematol Oncol. 2020;13(1):92. doi:10.1186/s13045-020-00929-8.
  • Yu J, Jiang PYZ, Sun H, et al. Advances in targeted therapy for acute myeloid leukemia. Biomark Res. 2020;8:1–11. doi:10.1186/s40364-020-00196-2.
  • Wang Y, Liu Y, Bailey C, et al. Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin. Oncogene. 2020;39(14):3015–3027. doi:10.1038/s41388-020-1201-z.
  • Yong SB, Chung JY, Kim SS, et al. CD64-targeted HO-1 RNA interference enhances chemosensitivity in orthotopic model of acute myeloid leukemia and patient-derived bone marrow cells. Biomaterials. 2020;230:119651. doi:10.1016/j.biomaterials.2019.119651.
  • Jiang MC, Ni JJ, Cui WY, et al. Emerging roles of lncRNA in cancer and therapeutic opportunities. Am J Cancer Res. 2019;9(7):1354–1366.
  • Ishida M, Selaru FM. miRNA-Based therapeutic strategies. Curr Pathobiol Rep. 2013;1(1):63–70. doi:10.1007/s40139-012-0004-5.
  • Zhou Q, Feng J, Yin S, et al. LncRNA FAM230B promotes the metastasis of papillary thyroid cancer by sponging the miR-378a-3p/WNT5A axis. Biochem Biophys Res Commun. 2021;546:83–89. doi:10.1016/j.bbrc.2021.01.109.
  • Cui Y, Pu R, Ye J, et al. LncRNA FAM230B promotes gastric cancer growth and metastasis by regulating the miR-27a-5p/TOP2A axis. Dig Dis Sci. 2020;66(8):2637–2650. doi:10.1007/s10620-020-06581-z.
  • Fang Z, Yin S, Sun R, et al. miR-140-5p suppresses the proliferation, migration and invasion of gastric cancer by regulating YES1. Mol Cancer. 2017;16(1):139. doi:10.1186/s12943-017-0708-6.
  • Metzeler KH, Herold T, Rothenberg-Thurley M, et al. Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia. Blood. 2016;128(5):686–698. doi:10.1182/blood-2016-01-693879.
  • Grimwade D, Hills RK, Moorman AV, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom medical research council trials. Blood. 2010;116(3):354–365. doi:10.1182/blood-2009-11-254441.
  • Röllig C, Bornhäuser M, Thiede C, et al. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system. J Clin Oncol. 2011;29(20):2758–2765.doi:10.1200/jco.2010.32.8500.
  • Lan H, Chen W, He G, et al. miR-140-5p inhibits ovarian cancer growth partially by repression of PDGFRA. Biomed Pharmacother. 2015;75:117–122. doi:10.1016/j.biopha.2015.07.035.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.